Skip to main content

WPI 2233 Pill: white, round, 10mm

The pill with imprint WPI 2233 (White, Round, 10mm) has been identified as Tamoxifen Citrate 20 mg and is used for Breast Cancer, Metastatic, Breast Cancer, Adjuvant, Breast Cancer, Male, Breast Cancer, and Breast Cancer, Palliative. It belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators and is not a controlled substance.

Images for WPI 2233

Tamoxifen citrate 20 mg WPI 2233
Tamoxifen citrate 20 mg WPI 2233
Tamoxifen citrate 20 mg WPI 2233 Front
Tamoxifen citrate 20 mg WPI 2233 Back
Tamoxifen citrate 20 mg WPI 2233
Tamoxifen citrate 20 mg WPI 2233

Tamoxifen Citrate

Imprint
WPI 2233
Strength
20 mg
Color
White
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Hormones/antineoplastics, Selective estrogen receptor modulators
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals, Inc.
National Drug Code (NDC)
00591-2233 (Discontinued)
Inactive Ingredients
croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, corn starch

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.